Geneos Wealth Management’s ProShares UltraShort FTSE Europe EPV Stock Holding History

Geneos Wealth Management’s Portfolio EPV Stock Details EPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,714	Closed	-$81.7K	–	2497
2026 Q1	$81.7K	Buy	+3,714	New	+$77.1K	﹤0.01%	1238

Other funds holding EPV

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

VAM

Verity Asset Management Durham, North Carolina $264M AUM 28.52% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geneos Wealth Management's EPV Position: Q2 2026 in Review

Geneos Wealth Management sold out of ProShares UltraShort FTSE Europe (EPV) in Q2 2026, closing a stake of 3,714 shares — an estimated $81.7K sold.

Geneos Wealth Management first reported a position in EPV in Q1 2026 and held it in 1 quarter. The position peaked at $81.7K in Q1 2026. 4 funds tracked by Wall St. Rank hold EPV as of Q2 2026.

Geneos Wealth Management reported no remaining ProShares UltraShort FTSE Europe position as of Q2 2026 after selling out during the quarter.
Geneos Wealth Management sold 3,714 ProShares UltraShort FTSE Europe shares in Q2 2026, an estimated $81.7K.
Geneos Wealth Management first reported a position in ProShares UltraShort FTSE Europe in Q1 2026 and held it in 1 quarter.
Geneos Wealth Management's ProShares UltraShort FTSE Europe position peaked at $81.7K in Q1 2026.
4 funds tracked by Wall St. Rank held ProShares UltraShort FTSE Europe as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.